Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Pulmonary Pharmacology & Therapeutics|July 4, 2024
Differential distribution of ivacaftor and its metabolites in plasma and human airway epitheliaZhongyu Liu, Justin D Anderson, Natalie R Rose, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 16, 2021
Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosisMegan Smith, Kevin J Ryan, Hector Gutierrez, et al.
JCI Insight|December 5, 2017
Nasospheroids permit measurements of CFTR-dependent fluid transportJennifer S Guimbellot, Justin M Leach, Imron G Chaudhry, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 13, 2022
Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysateKevin J Ryan, Jennifer S Guimbellot, Alexander E Dowell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 27, 2022
Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipientsKathleen J Ramos, Jennifer S Guimbellot, Maryam Valapour, et al.
Clinical and Translational Science|February 10, 2023
Pharmacogenetic actionability and medication prescribing in people with cystic fibrosisJustin D Anderson, Brittney H Davis, Gracie Giang, et al.
American Journal of Respiratory Cell and Molecular Biology|May 14, 2008
Role of oxygen availability in CFTR expression and functionJennifer S Guimbellot, James A Fortenberry, Gene P Siegal, et al.
The Journal of Biological Chemistry|April 7, 2004
Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell linesKároly Varga, Asta Jurkuvenaite, John Wakefield, et al.
The European Respiratory Journal|February 19, 2026
Impact of CFTR Modulator Concentrations on Clinical Response in Cystic FibrosisAshritha R Chalamalla, Elizabeth Baker, Kevin J Ryan, et al.
Jac-Antimicrobial Resistance|December 11, 2024
Evaluating the effects of ivacaftor exposure on <i>Staphylococcus aureus</i> small colony variant development and antibiotic toleranceGretchen E Bollar, Kendall M Shaffer, Johnathan D Keith, et al.
Pageof 4